# The convenience gap is closing. Amgen competitors noticed.

- slug: the-convenience-gap-is-closing-amgen-competitors-noticed
- date: 2026-04-06
- category: Biotech & Life Sciences

Amgen fixed the one thing keeping competitors in the race: a subcutaneous version of its blockbuster thyroid eye disease drug Tepezza. But the window it bought may be shorter than it looks.

---